78% of active Sunnyside Med members achieved a meaningful reduction in their drinking
Sulindac for polyposis of the colon
6 With the emergence of newer medications, including GLP-1 receptor agonists, patients with obesity can lose upwards of 15% to 20% of total body weight, achieving nearly the magnitude of weight loss seen with bariatric surgery
The conversation around weight management has evolved significantly, especially with the introduction of medications like Ozempic and tirzepatide
15 Overall, it favors that ALC could serve as a potential treatment and plays role as a potential biomarker for MDD
Third-party tested & certified Both peptides verified by MZ Biolabs (Tucson, AZ), an accredited US laboratory, via HPLC and mass spectrometry, with batch-linked COAs